SLC7A5 is essential for cancer cell growth, and studies have demonstrated that pharmacological inhibition and knockdown/knockout of SLC7A5 inhibit the proliferation of cancer cells and xenograft tumors [10–12]. The gene discussed is SLC7A5; the disease is cancer.